Company Filing History:
3 out of 96 
1 out of 18 Years Active: 2015-2024
Title: Innovations of John Reidhaar-Olson
Introduction
John Reidhaar-Olson is a notable inventor based in New York, NY, with a focus on biopharmaceutical innovations. He holds a total of four patents, showcasing his contributions to the field of genetic research and therapeutic development.
Latest Patents
Among his latest patents, Reidhaar-Olson has developed compositions and methods for inhibiting the expression of RRM2 genes. This invention involves a double-stranded ribonucleic acid (dsRNA) designed to inhibit the expression of the RRM2 gene. The patent also includes a pharmaceutical composition that comprises the dsRNA or nucleic acid molecules or vectors encoding the same, along with a pharmaceutically acceptable carrier. Furthermore, it outlines methods for treating diseases caused by the expression of the RRM2 gene using the pharmaceutical composition, as well as methods for inhibiting the expression of RRM2 in a cell.
Career Highlights
Reidhaar-Olson has made significant strides in his career, working with prominent companies such as Arrowhead Pharmaceuticals, Inc. and Arrowhead Research Corporation. His work has contributed to advancements in the understanding and treatment of genetic disorders.
Collaborations
Throughout his career, Reidhaar-Olson has collaborated with notable colleagues, including John Frederick Boylan and Markus Hossbach. These collaborations have further enriched his research and innovations in the field.
Conclusion
John Reidhaar-Olson's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in genetic therapies and treatments.